Background: This study aimed to investigate the effect of fascial manipulation (FM) of the deep cervical fascia (DCF) and sequential yoga poses (SYP) on pain and function in individuals with mechanical neck pain (MNP). Method: Following the predefined criteria, ninety-nine individuals with MNP were recruited, randomised, and assigned to either the intervention group (IG) (n = 51) or the control group (CG) (n = 48). Individuals in the IG received FM (4 sessions in 4 weeks) and the home-based SYP (4 weeks). The CG participants received their usual care (cervical mobilisation and thoracic manipulation (4 sessions in 4 weeks) along with unsupervised therapeutic exercises (4 weeks). The participants underwent baseline and weekly follow-up measurements of pain using a numerical pain rating scale (NPRS) and elbow extension range of motion (EEROM) during the upper limb neurodynamic test 1 (ULNT1). The baseline and the fourth session follow-up measurements of the patient-specific functional scale (PSFS) and fear-avoidance behavior Questionnaire (FABQ) were also taken. Results: A repeated-measures ANOVA was performed. There were statistically significant differences between the IG and CG on the NPRS third and fourth sessions, with mean differences (MD) of −1.009 (p < 0.05) and −1.701 (p < 0.001), respectively. Regarding EEROM, there was a 20.120° difference (p < 0.001) in the fourth session between the groups. The MD in FABQ was −5.036 (p < 0.001), but there were no significant differences in PSFS between the groups during the follow-up. Conclusion: FM and SYP can aid in reducing pain and fear-avoidance behaviour and improve the function and extensibility of the upper quarter region.
Although Reliability Block Diagrams (RBDs), are frequently employed for reliability analysis, their efficacy in healthcare applications is limited because they frequently fail to address the imprecision and uncertainty present in clinical data. By adding Neutrosophic Logic to RBDs, this work creates a novel method for improving reliability evaluations in ambiguous clinical settings. In contrast to conventional approaches, the Neutrosophic RBD model better represents the complexity of healthcare systems by integrating truth, indeterminacy, and falsity components. R programming is used to develop the model, and simulations are used to gauge how well it performs in various clinical settings. According to the simulations, the Neutrosophic RBD model outperforms conventional RBDs in managing uncertainty and enhancing decision-making, offering more flexibility and more precise reliability evaluations. This research establishes a foundation for future research that could broaden the application of this method to other decision-support systems, both within and beyond the healthcare sector.
Background: Cancer remains a leading cause of death worldwide, with a significant burden in India’s northeastern states, including Meghalaya. Patients from tribal communities often face unique sociocultural and communication barriers that affect their engagement in care. Effective patient–physician communication improves satisfaction, adherence, and quality of life. This study aims to assess the consultation satisfaction and effectiveness of a Question Prompt List (QPL) in enhancing patient–physician communication and promoting informed decision-making among cancer patients in a tribal population in Meghalaya, India. Methods: A quasi-experimental design was employed involving 60 participants diagnosed with head and neck, gastrointestinal, or respiratory cancers. Participants were assigned to an intervention group that received the QPL and a control group that received standard care. Data on consultation satisfaction and patient feedback were collected across two follow-up sessions. Results: The intervention group demonstrated statistically significant improvements in multiple domains of consultation satisfaction, including physicians’ responsiveness, patients’ confidence in asking questions, understanding of disease and treatment plans, and discussions of financial aspects. In contrast, the control group showed no significant change across follow-ups. Patient feedback indicated high levels of agreement regarding the QPL’s usefulness, clarity, and ability to facilitate meaningful communication. Conclusion: The QPL significantly enhanced patient satisfaction and engagement, demonstrating its effectiveness as a low-cost, culturally adaptable communication tool for oncology consultations among tribal populations. Integrating QPLs into routine oncology practice could strengthen patient-centred care and reduce communication barriers in underserved regions.
Triple‐therapy regimens involving Pregabalin or Gabapentin with nortriptyline and Methylcobalamin have been shown to be efficacious in treating neuropathic pain in clinical trials. This study aims to compare the clinical effectiveness and treatment satisfaction of two triple‐therapy regimens in treating neuropathic pain in a real‐world setting. This prospective, single‐center, observational study compared the efficacy, safety, and treatment satisfaction of triple therapy in Pregabalin triple therapy versus Gabapentin triple therapy for patients with neuropathic pain. The primary outcome measured the reduction in mean Self‐Administered Leeds Assessment of Neuropathic Symptoms and Signs pain score value from the baseline to 12 weeks posttreatment. The secondary outcome measured the treatment satisfaction for both therapies using the Treatment Satisfaction Questionnaire for Medication version 1.4. Of 264 patients who received either treatment group, during the third follow‐up, it became evident that Group A Pregabalin triple therapy yielded a significantly more substantial reduction in neuropathic pain (60.61%) when compared to Group B Gabapentin triple therapy (12.88%). Furthermore, patients expressed markedly higher levels of satisfaction and convenience with the Pregabalin treatment ( p ≤ 0.001). Our study's findings, encompassing both clinical effectiveness and treatment satisfaction, unequivocally demonstrate that Group A surpasses Group B in ameliorating neuropathic symptoms and signs. Pregabalin is a more effective and convenient treatment for neuropathic pain than Gabapentin, with no significant difference in side effects. Clinicians should consider Pregabalin as a first‐line treatment option for neuropathic pain, especially for patients not responding to Gabapentin or who seek a more convenient option.
The COVID-19 pandemic has significantly impacted global health, with recent studies suggesting long-term aftermath effects on physical activity (PA) and sleep among recovered individuals. Pre-existing challenges, such as high rates of physical inactivity and sleep deprivation in the United Arab Emirates (UAE), may exacerbate these effects. This cross-sectional study compared accelerometer-measured PA and self-reported sleep between 65 individuals who had recovered from COVID-19 within the past year (mean age 23.28 ± 6.05 years; 56 had acute COVID-19; 6 had ongoing symptoms up to 12 weeks, and 3 had post-COVID-19 syndrome) and 65 age- and sex-matched healthy controls (mean age 22.54 ± 4.32 years) in the UAE. Sociodemographic, anthropometric, and COVID-19 symptom history were collected through structured questionnaires. PA was measured using a thigh worn Fibion accelerometer for 4–7 consecutive days, including sitting, light, moderate, and vigorous intensity activity durations. Sleep was assessed using the Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), and Epworth Sleepiness Scale (ESS). Mann-Whitney U tests and chi-square analyses were used. No significant differences in sitting and PA durations were observed between the two groups. However, individuals recovered from COVID-19 exhibited longer sleep latency (29.15 min vs. 19.88 min, p = 0.033) compared to healthy controls. Other sleep parameters, such as sleep duration, efficiency, and daytime dysfunction, showed no statistically significant differences. Additionally, no associations were found between COVID-19 recovery and insomnia prevalence or excessive daytime sleepiness. These findings suggest that individuals primarily recovered from acute COVID-19 may not present with significant impairments in PA or sleep quality. However, the results also highlight the importance of individualized assessment and the need for further research to understand the broader spectrum of post-COVID cases (acute to post-COVID syndrome) and associated recovery outcomes.